Won't take action on summons issued to Subhash Chandra for three weeks: Sebi to HC

Sebi's response came on a writ petition filed by Chandra, chairman emeritus of Zee Entertainment, on March 5 challenging the summons issued to him in connection with an ongoing probe by the market regulator.

Mumbai: The Securities and Exchange Board of India () on Wednesday informed the Bombay High Court that it will not take any action against chairman for three weeks in connection with summons it had issued.

Sebi's response came on a writ petition filed by Chandra, chairman emeritus of , on March 5 challenging the summons issued to him in connection with an ongoing probe by the regulator.

Appearing for Chandra, senior counsel Ravi Kadam told the court that the summons were for producing with respect to the Sebi investigation. "However, under the guise of summons, all kinds of conclusive findings were brought, which tantamount to a show cause notice," he argued.

Senior counsel Mustafa Doctor, appearing for Sebi, sought two weeks to file its response and gave an undertaking that Sebi would not take any action for the three weeks with regards to the summons.


Source: Stocks-Markets-Economic Times

Останні публікації
Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps
20.09.2024 - 18:00
RBC says this stock is a 'top mid-cap cybersecurity idea,' starts coverage at Buy
20.09.2024 - 18:00
Ryman Hospitality Properties director sells $96,588 in company stock
20.09.2024 - 18:00
Trump Media shares drop after lock-up expires
20.09.2024 - 18:00
ECB Bancorp CFO acquires $69.9k in company stock
20.09.2024 - 18:00
Earnings call: Alliance Entertainment announces mixed FY 2024 results
20.09.2024 - 18:00
Fed's relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports
20.09.2024 - 18:00
Nike veteran Hill to replace Donahoe as CEO; shares jump  
20.09.2024 - 18:00
Novo Nordisk shares drop more than 4% on disappointing obesity pill data
20.09.2024 - 18:00
Johnson Controls EVP and CFO sells $13.7k in stock
20.09.2024 - 18:00
'Temu Threat Abating in 2Q24' - Barclays
20.09.2024 - 18:00
Here's why BTIG says they would be "patient buyers" after large Fed rate cut
20.09.2024 - 18:00
US FDA approves Zevra's treatment for rare genetic disease
20.09.2024 - 18:00
Premier Inc. CFO Craig McKasson sells $204,100 worth of shares
20.09.2024 - 18:00
Earnings call: iPower reports mixed results, optimistic about 2025
20.09.2024 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз трейдера Аналіз трейдера за 20.09.24
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.